Literature DB >> 12432781

Regulation of dopamine cell type and transmitter function in fetal and stem cell transplantation for Parkinson's disease.

Lars M Björklund1, Ole Isacson.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2002        PMID： 12432781     DOI： 10.1016/S0079-6123(02)38090-7

Source DB:  PubMed          Journal:  Prog Brain Res        ISSN： 0079-6123            Impact factor:   2.453


× No keyword cloud information.
  10 in total

1.  Tracing synaptic connectivity onto embryonic stem cell-derived neurons.

Authors:  Isabella Garcia; Longwen Huang; Kevin Ung; Benjamin R Arenkiel
Journal:  Stem Cells       Date:  2012-10       Impact factor: 6.277

2.  Otx2 controls neuron subtype identity in ventral tegmental area and antagonizes vulnerability to MPTP.

Authors:  Michela Di Salvio; Luca Giovanni Di Giovannantonio; Dario Acampora; Raffaele Prosperi; Daniela Omodei; Nilima Prakash; Wolfgang Wurst; Antonio Simeone
Journal:  Nat Neurosci       Date:  2010-11-07       Impact factor: 24.884

3.  Identification of dopaminergic neurons of nigral and ventral tegmental area subtypes in grafts of fetal ventral mesencephalon based on cell morphology, protein expression, and efferent projections.

Authors:  Lachlan Thompson; Perrine Barraud; Elin Andersson; Deniz Kirik; Anders Björklund
Journal:  J Neurosci       Date:  2005-07-06       Impact factor: 6.167

Review 4.  In vitro neurogenesis: development and functional implications of iPSC technology.

Authors:  Claudia Compagnucci; Monica Nizzardo; Stefania Corti; Ginevra Zanni; Enrico Bertini
Journal:  Cell Mol Life Sci       Date:  2013-11-20       Impact factor: 9.261

5.  Cell type analysis of functional fetal dopamine cell suspension transplants in the striatum and substantia nigra of patients with Parkinson's disease.

Authors:  Ivar Mendez; Rosario Sanchez-Pernaute; Oliver Cooper; Angel Viñuela; Daniela Ferrari; Lars Björklund; Alain Dagher; Ole Isacson
Journal:  Brain       Date:  2005-05-04       Impact factor: 13.501

6.  Neurons derived from reprogrammed fibroblasts functionally integrate into the fetal brain and improve symptoms of rats with Parkinson's disease.

Authors:  Marius Wernig; Jian-Ping Zhao; Jan Pruszak; Eva Hedlund; Dongdong Fu; Frank Soldner; Vania Broccoli; Martha Constantine-Paton; Ole Isacson; Rudolf Jaenisch
Journal:  Proc Natl Acad Sci U S A       Date:  2008-04-07       Impact factor: 11.205

7.  Cytochrome p450 cyp26a1 alters spinal motor neuron subtype identity in differentiating embryonic stem cells.

Authors:  Megan J Ricard; Lorraine J Gudas
Journal:  J Biol Chem       Date:  2013-08-13       Impact factor: 5.157

8.  Stem cell therapy for Parkinson's disease.

Authors:  Lars M Björklund
Journal:  Dialogues Clin Neurosci       Date:  2004-09       Impact factor: 5.986

9.  Implanted reuptake-deficient or wild-type dopaminergic neurons improve ON L-dopa dyskinesias without OFF-dyskinesias in a rat model of Parkinson's disease.

Authors:  A Vinuela; P J Hallett; C Reske-Nielsen; M Patterson; T D Sotnikova; M G Caron; R R Gainetdinov; O Isacson
Journal:  Brain       Date:  2008-11-06       Impact factor: 13.501

10.  Dopamine transporter neuroimaging accurately assesses the maturation of dopamine neurons in a preclinical model of Parkinson's disease.

Authors:  Julian L Goggi; Lifeng Qiu; Mei Chih Liao; Shivashankar Khanapur; Lingfan Jiang; Ramasamy Boominathan; Siddesh V Hartimath; Peter Cheng; Fui Fong Yong; Vanessa Soh; Xiaozhou Deng; Youshan Melissa Lin; Anna Haslop; Peng Wen Tan; Xiaoxia Zeng; Jolene W L Lee; Zhiwei Zhang; Pragalath Sadasivam; Eng King Tan; Sajinder K Luthra; William D Shingleton; Steve K W Oh; Li Zeng; Edward G Robins
Journal:  Stem Cell Res Ther       Date:  2020-08-08       Impact factor: 6.832
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.